The Procter & Gamble Company
NYSEPG short interest surges 22.3% in one week to 1.18% of free float, driven by renewed positioning after earnings pressure.
A new long-form analysis for PG this week — anomalies vs the company's own history, peer comparisons, news context, and the full data picture. Premium subscribers only.
Read on ORTEX →Sign up for premiumProcter & Gamble has just cleared its fiscal Q4 2026 print, and the question is no longer what the numbers say but whether the market decides the stock deserves to close its underperformance gap against a peer group…
Snapshot as of 26 Aug 2026
Procter & Gamble arrives at its fiscal Q4 2026 print having recovered from the $147 trough flagged in the last two reports, with the stock closing at $148.88 — up half a percent on the week and essentially flat over…
Procter & Gamble heads into its July 28 quarterly report having given back the $150 recovery celebrated just days ago, with options positioning now the calmest it has been all cycle. The stock closed at $147.41 on July…
Procter & Gamble heads into the final stretch of its fiscal year with the Street still broadly bullish — but quietly trimming expectations — while the stock trades at a one-month low after shedding 3.5% over May. The…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for PG — free to start on ORTEX.
Sign up for free →Open PG on ORTEX